Product correctly added to cart.

discount label
Cyclopentanecarbohydrazide
View 3D

Biosynth logo

Cyclopentanecarbohydrazide

CAS: 3400-07-5

Ref. 3D-FC114123

1gTo inquire
2gTo inquire
5gTo inquire
10gTo inquire
500mgTo inquire
Estimated delivery in United States, on Tuesday 7 Jan 2025

Product Information

Name:
Cyclopentanecarbohydrazide
Synonyms:
  • Cyclopentanecarboxylic Acid, Hydrazide
Description:

Cyclopentanecarbohydrazide is a metabolic disorder drug that is used in the treatment of cancer, including leukemia. It has been shown to inhibit the growth of cancer cells by binding to the CB1 receptor. Cyclopentanecarbohydrazide also shows anti-inflammatory effects and can be used for the treatment of inflammatory diseases such as psoriasis or Crohn's disease. Cyclopentanecarbohydrazide binds to glutamate, which is an excitatory neurotransmitter and activates a number of receptors in the brain. Cyclopentanecarbohydrazide can be used for the treatment of depression or type II diabetes mellitus (T2DM).

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
128.17 g/mol
Formula:
C6H12N2O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FC114123 Cyclopentanecarbohydrazide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".